Rani Therapeutics Inc. (RANI)
1.31
0.03 (2.34%)
At close: Jan 15, 2025, 3:59 PM
1.31
-0.38%
After-hours Jan 15, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -33.97M | -63.34M | -53.09M | -16.70M | -26.59M |
| Depreciation & Amortization | 822.00K | 548.00K | 497.00K | 589.00K | 564.00K |
| Stock-Based Compensation | 19.01M | 15.78M | 22.59M | n/a | n/a |
| Other Working Capital | -1.54M | 346.00K | -3.97M | 111.00K | 108.00K |
| Other Non-Cash Items | -34.96M | -10.00K | 109.00K | 110.00K | -81.00K |
| Deferred Income Tax | n/a | n/a | 1.07M | n/a | n/a |
| Change in Working Capital | -2.14M | 509.00K | -3.43M | 1.04M | -163.00K |
| Operating Cash Flow | -51.24M | -46.52M | -32.24M | -14.96M | -26.27M |
| Capital Expenditures | -1.23M | -1.62M | -506.00K | -1.20M | -1.58M |
| Acquisitions | n/a | -851.00K | n/a | n/a | 49.00K |
| Purchase of Investments | -73.26M | -73.82M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 104.35M | 3.00M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 851.00K | n/a | n/a | 49.00 |
| Investing Cash Flow | 29.86M | -72.44M | -506.00K | -1.20M | -1.53M |
| Debt Repayment | n/a | 29.57M | -2.85M | 4.19M | n/a |
| Common Stock Repurchased | -162 | -626 | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 233.00K | -569.00K | 86.31M | 68.49M | 852.00K |
| Financial Cash Flow | 233.00K | 29.00M | 77.15M | 72.68M | 852.00K |
| Net Cash Flow | -21.14M | -89.95M | 44.40M | 56.52M | -26.95M |
| Free Cash Flow | -52.47M | -48.13M | -32.75M | -16.16M | -27.85M |